Header cover image

Canadian (TSX) Biotech Industry Analysis

UpdatedMay 26, 2022
DataAggregated Company Financials
Companies38
  • 7D-4.1%
  • 3M-5.7%
  • 1Y-25.3%
  • YTD-21.6%

Over the last 7 days, the Biotech industry has dropped 4.1%, driven by a pullback from BELLUS Health of 10%. The industry has fallen 25% in the last year. Looking forward, earnings are forecast to grow by 39% annually.

Industry Valuation and Performance

Has the Canadian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sat, 28 May 2022CA$3.1bCA$180.1m-CA$456,438,515.0012.7x
Mon, 25 Apr 2022CA$3.4bCA$175.8m-CA$489,690,985.0014x
Wed, 23 Mar 2022CA$3.3bCA$171.0m-CA$479,666,992.0013.8x
Fri, 18 Feb 2022CA$3.5bCA$167.6m-CA$454,286,480.0017.8x
Sun, 16 Jan 2022CA$3.4bCA$166.4m-CA$429,998,987.0019.6x
Tue, 14 Dec 2021CA$5.9bCA$172.9m-CA$495,408,256.005.2x
Thu, 11 Nov 2021CA$6.0bCA$171.0m-CA$424,877,138.007.4x
Sat, 09 Oct 2021CA$7.9bCA$240.5m-CA$608,032,848.008.1x
Mon, 06 Sep 2021CA$8.0bCA$222.8m-CA$562,923,623.087.2x
Wed, 04 Aug 2021CA$3.4bCA$161.7m-CA$474,887,008.0826.2x
Sat, 08 May 2021CA$4.4bCA$154.4m-CA$492,315,138.3116x
Tue, 09 Feb 2021CA$3.8bCA$64.4m-CA$334,394,309.2222.6x
Mon, 02 Nov 2020CA$3.7bCA$144.2m-CA$423,056,348.426.1x
Thu, 06 Aug 2020CA$3.2bCA$155.6m-CA$395,109,095.796.9x
Sun, 10 May 2020CA$3.1bCA$155.4m-CA$339,174,105.6742.4x
Sat, 01 Feb 2020CA$2.8bCA$161.7m-CA$234,737,086.87n/a
Tue, 05 Nov 2019CA$1.8bCA$164.5m-CA$244,388,675.87744.4x
Fri, 09 Aug 2019CA$1.9bCA$163.5m-CA$234,009,186.88n/a
Median PE Ratio

n/a


Total Market Cap: CA$1.9bTotal Earnings: -CA$206,938,076.32Total Revenue: CA$165.0mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Biotech Industry Median PE3Y Average 76.5x202020212022
Current Industry PE
  • Investors are more pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 12.7x which is lower than its 3-year average PE of 98.4x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 3.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Canadian Biotech compare with similar industries?

CA Market1.68%
Healthcare0.16%
Biotech-4.11%
Biotech-4.11%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TH TheratechnologiesCA$3.147.2%
+CA$20.0m
-25.6%PS3.2x
MGRO MustGrow BiologicsCA$3.057.0%
+CA$9.8m
60.5%PS10517.2x
MBX Microbix BiosystemsCA$0.579.6%
+CA$6.9m
-3.4%PS20x
ONC Oncolytics BiotechCA$1.457.4%
+CA$5.8m
-60.7%PB2.4x
COV Covalon TechnologiesCA$2.097.2%
+CA$3.7m
44.1%PS156.9x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IMV

CA$1.16

IMV

7D

-11.5%

1Y

-60.4%

RVX

CA$0.26

Resverlogix

7D

-13.3%

1Y

-71.4%